AAAAAA
Results:
1-23
|
Results: 23
Authors:
Benigni, A
Perico, N
Remuzzi, G
Citation: A. Benigni et al., Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression, CURR OP NEP, 10(1), 2001, pp. 1-6
Authors:
Noris, M
Azzollini, N
Pezzotta, A
Mister, M
Benigni, A
Marchetti, G
Gagliardini, E
Perico, N
Remuzzi, G
Citation: M. Noris et al., Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renalallograft, J AM S NEPH, 12(9), 2001, pp. 1937-1946
Blocking angiotensin II synthesis/activity preserves glomerular nephrin inrats with severe nephrosis
Authors:
Benigni, A
Tomasoni, S
Gagliardini, E
Zoja, C
Grunkemeyer, JA
Kalluri, R
Remuzzi, G
Citation: A. Benigni et al., Blocking angiotensin II synthesis/activity preserves glomerular nephrin inrats with severe nephrosis, J AM S NEPH, 12(5), 2001, pp. 941-948
Authors:
Tomasoni, S
Remuzzi, G
Benigni, A
Citation: S. Tomasoni et al., Gene therapy to the kidney, CONTR NEPHR, 136, 2001, pp. 140-156
Authors:
Benigni, A
Remuzzi, G
Citation: A. Benigni et G. Remuzzi, How renal cytokines and growth factors contribute to renal disease progression, AM J KIDNEY, 37(1), 2001, pp. S21-S24
Authors:
Zoja, C
Benigni, A
Noris, M
Corna, D
Casiraghi, F
Pagnoncelli, M
Rottoli, D
Abbate, M
Remuzzi, G
Citation: C. Zoja et al., Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis, KIDNEY INT, 60(2), 2001, pp. 653-663
Authors:
Benigni, A
Gagliardini, E
Remuzzi, A
Corna, D
Remuzzi, G
Citation: A. Benigni et al., Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist, AM J PATH, 159(5), 2001, pp. 1743-1750
Authors:
Tomasoni, S
Azzollini, N
Casiraghi, F
Capogrossi, MC
Remuzzi, G
Benigni, A
Citation: S. Tomasoni et al., CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft, J AM S NEPH, 11(4), 2000, pp. 747-752
Authors:
Benigni, A
Citation: A. Benigni, Tubulointerstitial disease mediators of injury: the role of endothelin, NEPH DIAL T, 15, 2000, pp. 50-52
Authors:
Donadelli, R
Abbate, M
Zanchi, C
Corna, D
Tomasoni, S
Benigni, A
Remuzzi, G
Zoja, C
Citation: R. Donadelli et al., Protein traffic activates NF-kappa B gene signaling and promotes MCP-1-dependent interstitial inflammation, AM J KIDNEY, 36(6), 2000, pp. 1226-1241
Authors:
Galbusera, M
Remuzzi, A
Benigni, A
Rossi, C
Remuzzi, G
Citation: M. Galbusera et al., A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow, AM J KIDNEY, 36(4), 2000, pp. 695-702
Authors:
Benigni, A
Perico, N
Remuzzi, G
Citation: A. Benigni et al., Endothelin antagonists and renal protection, J CARDIO PH, 35, 2000, pp. S75-S78
Authors:
Benigni, A
Remuzzi, G
Citation: A. Benigni et G. Remuzzi, Prostacyclin and thromboxane and the development of preeclampsia, J AM MED A, 283(12), 2000, pp. 1568-1568
Authors:
Remuzzi, G
Benigni, A
Citation: G. Remuzzi et A. Benigni, Repairing renal lesions: Will VEGF be the builder?, KIDNEY INT, 58(6), 2000, pp. 2594-2595
Authors:
Benigni, A
Madias, NE
Remuzzi, G
Siragy, HM
Brooks, DP
Rossi, GP
Abbate, M
Ong, A
Loeffler, BM
Bender, N
Noris, M
Ruggenenti, P
Wilson, C
Citation: A. Benigni et al., Endothelin antagonists in renal disease, KIDNEY INT, 57(4), 2000, pp. 1778-1794
Authors:
Benigni, A
Tomasoni, S
Lutz, J
Amuchastegui, S
Capogrossi, MC
Remuzzi, G
Citation: A. Benigni et al., Nonviral and viral gene transfer to the kidney in the context of transplantation, NEPHRON, 85(4), 2000, pp. 307-316
Authors:
Remuzzi, G
Zoja, C
Gagliardini, E
Corna, D
Abbate, M
Benigni, A
Citation: G. Remuzzi et al., Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals, J AM S NEPH, 10(7), 1999, pp. 1542-1549
Authors:
Galbusera, M
Benigni, A
Paris, S
Ruggenenti, P
Zoja, C
Rossi, C
Remuzzi, G
Citation: M. Galbusera et al., Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, J AM S NEPH, 10(6), 1999, pp. 1234-1241
Authors:
Zoja, C
Benigni, A
Remuzzi, G
Citation: C. Zoja et al., Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators, EXP NEPHROL, 7(5-6), 1999, pp. 420-428
Authors:
Abbate, M
Benigni, A
Bertani, T
Remuzzi, G
Citation: M. Abbate et al., Nephrotoxicity of increased glomerular protein traffic, NEPH DIAL T, 14(2), 1999, pp. 304-312
Authors:
Benigni, A
Zoja, C
Noris, M
Corna, D
Benedetti, G
Bruzzi, I
Todeschini, M
Remuzzi, G
Citation: A. Benigni et al., Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model, AM J KIDNEY, 33(4), 1999, pp. 746-753
Authors:
Benigni, A
Remuzzi, G
Citation: A. Benigni et G. Remuzzi, Endothelin antagonists, LANCET, 353(9147), 1999, pp. 133-138
Authors:
Benigni, A
Bruzzi, I
Mister, M
Azzollini, N
Gaspari, F
Perico, N
Gotti, E
Bertani, T
Remuzzi, G
Citation: A. Benigni et al., Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year, KIDNEY INT, 55(2), 1999, pp. 674-685
Risultati:
1-23
|